Wolverine Trading, LLC Charles River Laboratories International, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $150,368 - $196,232	-800 Reduced 11.94%	5,900 $1.16 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $990,671 - $1.29 Million	4,800 Added 252.63%	6,700 $1.38 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $203,520 - $273,430	-1,000 Reduced 34.48%	1,900 $514,000
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $329,040 - $477,680	-2,000 Reduced 40.82%	2,900 $685,000
Q3 2023 Nov 15, 2023	BUY	$194.44 - $217.61 $155,552 - $174,088	800 Added 19.51%	4,900 $960,000
Q2 2023 Aug 23, 2023	BUY	$183.71 - $210.25 $753,211 - $862,025	4,100 New	4,100 $862,000
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $413,931 - $525,147	2,100 Added 80.77%	4,700 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $492,588 - $676,458	-2,700 Reduced 50.94%	2,600 $494,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $489,912 - $725,760	-2,400 Reduced 31.17%	5,300 $1.16 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $2.76 Million - $3.91 Million	-10,800 Reduced 58.38%	7,700 $2.23 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $140,552 - $179,472	-400 Reduced 2.12%	18,500 $6.95 Million
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $4.88 Million - $6 Million	13,100 Added 225.86%	18,900 $8 Million
Q2 2021 Aug 06, 2021	BUY	$294.17 - $371.65 $735,425 - $929,125	2,500 Added 75.76%	5,800 $2.16 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $798,944 - $958,336	-3,200 Reduced 49.23%	3,300 $950,000
Q4 2020 Feb 12, 2021	SELL	$222.0 - $252.62 $155,400 - $176,834	-700 Reduced 9.72%	6,500 $1.62 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $3.09 Million - $3.99 Million	-17,600 Reduced 70.97%	7,200 $1.61 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $2.13 Million - $3.4 Million	17,900 Added 259.42%	24,800 $4.19 Million
Q1 2020 May 11, 2020	SELL	$98.9 - $178.34 $148,350 - $267,510	-1,500 Reduced 17.86%	6,900 $897,000
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $1.05 Million - $1.21 Million	8,400 New	8,400 $1.11 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $605,394 - $726,516	-5,400 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $648,054 - $760,320	-6,600 Reduced 55.0%	5,400 $576,000
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $1.21 Million - $1.42 Million	12,000	12,000 $1.31 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.14 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$948 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$697 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$397 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$361 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.48B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account